Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Hirvonen J et al. |
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and (carbonyl-11C)WAY-100635 - considerations on the validity of cerebellum as a reference region.
|
|
2 |
Honkonen T et al. |
Employment predictors for discharged schizophrenia patients.
|
|
3 |
Karlsson L et al. |
Lapsuuden stressi uhkaa aikuisiän terveyttä.
|
|
4 |
Koikkalainen J et al. |
Shape variability of the human striatum - effects of age and gender.
|
|
5 |
Korkeila J et al. |
Use of antidepressants and suicide rate in Finland: an ecological study.
|
|
6 |
Korkeila JA et al. |
Physical ill health and risk of psychosis.
|
|
7 |
Lumme V et al. |
Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning.
|
|
8 |
Luutonen S. |
Sepelvaltimotautipotilaan masennuksen diagnostiikka ja hoito.
|
|
9 |
Luutonen S. |
Sydän ja masennus.
|
|
10 |
Luutonen S. |
Anger and depression - theoretical and clinical considerations.
|
|
11 |
Markkula J. |
On Restless Legs in Psychiatry. Clinical Observations on RLS from a Psychiatric Point of View.
|
|
12 |
Martikainen IK et al. |
Correlation of human cold pressor pain responses with 5-HT 1A receptor binding in the brain.
|
|
13 |
Mattila AK et al. |
Alexithymia and life satisfaction in primary healthcare patients.
|
|
14 |
McGlashan TH et al. |
Recruitment and treatment practices for help-seeking "prodromal" patients.
|
|
15 |
Nyman MJ et al. |
Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with (18F)SPA-RQ.
|
|
16 |
Poutanen O et al. |
The depression scale as a screening instrument for a subsequent depressive episode in primary healtcare patients.
|
|
17 |
Poutanen O et al. |
Seven-year outcomeof depression in primary and psychiatric outpatient care: results of the Tadep (Tampere Depressio) II study.
|
|
18 |
Salokangas RKR. |
Psykoosin hoidosta riskivaiheen hoitoon.
|
|
19 |
Salokangas RKR. |
Medical problems in schizophrenia patients living in the community (alternative facilities).
|
|
20 |
Salokangas RKR. |
Nuoren vakavan mielenterveyshäiriön tunnistaminen on vaikeaa, mutta ei mahdotonta.
|
|
21 |
Salokangas RKR, Hietala J. |
Insuliini - ensimmäinen skitsofreniaa ehkäisevä lääke?
|
|
22 |
Salokangas RKR et al. |
Social role behaviour of patients with long-term schizophrenia in the community during sharp decline in number of psychiatric beds.
|
|
23 |
Salokangas RKR et al. |
Body mass index and functioning in long-term schizophrenia: results of the DSP project.
|
|
24 |
Salokangas RKR et al. |
Vulnerability to psychosis increases the risk of depression. Results of the RADEP study.
|
|
25 |
Svirskis T. |
Clinical Characterization of Subjects Wulnerable to Psychosis.
|
|
26 |
Svirskis T et al. |
Quality of life and functioning ability in subjects vulnerable to psychosis.
|
|
27 |
Wallius E et al. |
Voxel-based NK 1 receptor occupancy measurements with (18F)SPA-RQ and positron emission tomogrphy: A procedure for assessing errors from image reconstruction and physiological modeling.
|
|
28 |
Wolf J et al. |
A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad effectiveness trial with Aripiprazole in Europe (EU-BETA).
|